China CAS:595-33-5 Manufacturer

August 2022
Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
99% manufactures meets the requirements of GMP.
Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.

​IPhEB Russia 2025 will be held at EXPOFORUM Convention and Exhibition Centre from April 08-10,2025, our booth number is 320.

Ever found yourself scrolling through endless course listings, wondering which one actually bridges the gap between theory and a tangible, portfolio-worthy project? I’ve been there. With two decades in the tech industry, I’ve seen countless learners in the Intermediates Category hit a frustrating plateau. They know the basics but struggle to apply them convincingly in real-world scenarios. This is the core pain point we aimed to solve.

I've spent over twenty years working with companies like yours, and if there's one question I hear more than any other, it's this one. Selecting the right intermediates can feel like a high-stakes puzzle, where one wrong piece can impact your entire production line. It’s a decision that goes beyond mere cost; it's about partnership, reliability, and the integrity of your final product. In my journey, I've seen how a strategic partnership with a focused manufacturer like Humanwell Pharmaceutical can transform this challenging task from a source of anxiety into a competitive advantage. Let's break down the critical parameters you need to consider.

At Humanwell, our two decades of experience are dedicated to mastering these very compounds. We understand that the purity, stability, and reliability of every Intermediates Category directly determine the safety, efficacy, and scalability of the final drug. This blog will delve into the indispensable role these molecules play and how Humanwell ensures your manufacturing process is built on a foundation of excellence.

As pharmaceutical innovation continues to advance, the demand for highly pure steroid intermediates has increased significantly. Among these compounds, 4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic acid has attracted considerable attention due to its unique molecular structure, stability, and importance in the synthesis of several biologically active steroid derivatives.